Yaws
3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
New World MedicalCA - Rancho Cucamonga
3 programs2
1
R1-Total community treatment with azithromycinPhase 41 trial
AzithromycinPhase 31 trial
AzithromycinPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
New World MedicalR1-Total community treatment with azithromycin
New World MedicalAzithromycin
New World MedicalAzithromycin
Clinical Trials (3)
Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication
Start: Apr 2018Est. completion: Apr 2020
Phase 4Completed
Comparison of Two Different Doses of Azithromycin for Treatment of Yaws
Start: Jun 2015Est. completion: Dec 2016
Phase 3Completed
Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea
Start: Mar 2013Est. completion: May 2017
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space